Ataciguat, also known as HMR-1766, is a potent guanylate cyclase activator potentially for the treatment of aortic valve stenosis. HMR-1766 is a promising agent for treating diseases associated with increased vascular tone combined with enhanced ROS production. Ataciguat improves vascular function and reduces platelet activation in heart failure.
MedKoo Cat#: 124418
Name: Ataciguat Sodium
CAS#: 254976-06-2 (Sodium)
Chemical Formula: C21H18Cl2N3NaO6S3
Exact Mass: 596.9600
Molecular Weight: 598.46
Elemental Analysis: C, 42.15; H, 3.03; Cl, 11.85; N, 7.02; Na, 3.84; O, 16.04; S, 16.07
The following data is based on the product molecular weight 598.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |